期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Pancreaticoduodenal artery aneurysm associated with coeliac artery occlusion from an aortic intramural hematoma 被引量:2
1
作者 Akihiko Sakatani Yoshinori Doi +6 位作者 Toshiaki Kitayama Takaaki Matsuda yasutaka sasai Naohiro Nishida Megumi Sakamoto Naoto Uenoyama Kazuo Kinoshita 《World Journal of Gastroenterology》 SCIE CAS 2016年第16期4259-4263,共5页
Pancreaticoduodenal artery aneurysms are a rare type of visceral artery aneurysm, whose rupture is associated with high mortality. These aneurysms are of particular interest because local haemodynamic change caused by... Pancreaticoduodenal artery aneurysms are a rare type of visceral artery aneurysm, whose rupture is associated with high mortality. These aneurysms are of particular interest because local haemodynamic change caused by coeliac artery obstruction plays an important role in their development. However, the pathophysiological mechanism of coeliac artery obstruction is not completely understood. Pressure from the median arcuate ligament is most frequently reported cause. Although it is well-known that stenosis or occlusion of the visceral vessels may be caused by aortic syndrome, reports of pancreaticoduodenal artery aneurysm associated with coeliac artery occlusion due to aortic syndrome are extremely rare. Our case indicates a new aetiology for a pancreaticoduodenal artery aneurysm and demonstrates the rapid deterioration of the patient affected. 展开更多
关键词 Pancreaticoduodenal ARTERY COELIAC ARTERY VISCERAL ARTERY ANEURYSM AORTIC DISSECTION
下载PDF
Protracted anaphylaxis developed after peginterferon α-2a administration for chronic hepatitis C 被引量:1
2
作者 Akihiko Sakatani Yoshinori Doi +6 位作者 Takaaki Matsuda yasutaka sasai Naohiro Nishida Megumi Sakamoto Naoto Uenoyama Yoshiya Matsumoto Kazuo Kinoshita 《World Journal of Gastroenterology》 SCIE CAS 2015年第9期2826-2829,共4页
Peginterferon is a key drug used to treat chronic viral hepatitis that is known for causing various side effects.Side effects occurring immediately after administration include headache, nausea, and influenza-like sym... Peginterferon is a key drug used to treat chronic viral hepatitis that is known for causing various side effects.Side effects occurring immediately after administration include headache, nausea, and influenza-like symptoms, such as fever and joint pain.However, reports of anaphylactic shock are extremely rare.Here we report a patient with protracted anaphylaxis who suffered shock symptoms after peginterferon α-2a administration for chronic hepatitis C.Although the patient improved temporarily with shock treatment, symptoms of anaphylaxis recurred.As peginterferon is often administered on an outpatient basis, it is important to recognize life-threatening side effects that may develop in a protracted manner. 展开更多
关键词 PEGINTERFERON Α-2A ANAPHYLAXIS Anaphylactic shock
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部